BioMarin Pharmaceutical financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

바이오마린 파머슈티컬NASDAQ:BMRN · Nasdaq · Healthcare · sector #17

$56.22-2.29%

2026-10-06 close

BioMarin Pharmaceutical's published financial data is dated 2026-10-04. 2024 revenue was $2.85B. 2024 operating profit was $484M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy